Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study

World J Gastroenterol. 2017 Oct 21;23(39):7160-7167. doi: 10.3748/wjg.v23.i39.7160.

Abstract

Aim: To identify the potential risk factors of cholangiocarcinoma, we determined the characteristics of cholangiocarcinoma patients among 5 different regions of Thailand.

Methods: All patients diagnosed with cholangiocarcinoma between 2008 and 2013 were identified using the Nationwide Hospital Admission Data registry (n = 39421). Baseline characteristics, comorbidities and survival were abstracted.

Results: The annual incidence during the study period was stable in all regions. Most patients lived in the Northeast (62.8%), followed by the North (16.9%), Central (12.3%), Bangkok (5.4%), and South (n = 2.6%) regions (P < 0.0001). Significantly more cholangiocarcinoma patients had diabetes, cirrhosis, and chronic viral hepatitis B/C infection than non-cholangiocarcinoma participants (diabetes: 11.42% vs 5.28%; cirrhosis: 4.81% vs 0.92%; hepatitis B: 0.74% vs 0.12%; and hepatitis C: 0.50% vs 0.10%, P < 0.0001 for all, respectively). The overall 1-year mortality rate was 81.7%, with a stable trend over time.

Conclusion: Diabetes and chronic liver diseases may be associated with cholangiocarcinoma in the Thai population.

Keywords: Bile duct cancer; Epidemiology; Liver fluke infection; Population-based study.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Bile Duct Neoplasms / epidemiology*
  • Bile Duct Neoplasms / mortality
  • Bile Duct Neoplasms / pathology
  • Bile Duct Neoplasms / therapy
  • Cholangiocarcinoma / epidemiology*
  • Cholangiocarcinoma / mortality
  • Cholangiocarcinoma / pathology
  • Cholangiocarcinoma / therapy
  • Comorbidity
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Registries
  • Risk Factors
  • Thailand / epidemiology
  • Time Factors
  • Treatment Outcome